Opinion: ‘Anchoring’ was at work in setting the price of Novartis’ new gene therapy
ADOBE
In the U.S., drugs are priced at what the market will bear. A concept known as anchoring helped prime us for the $2.1 million price tag for Zolgensma.
Clinical and Molecular Allergy
Hace 8 horas
No hay comentarios:
Publicar un comentario